Ricin scare a risk to HPA plan

UK's Health Protection Agency questioned in the light of bioterrorism attack.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The arrest in London on Sunday morning of seven people for the manufacture of ricin, under the Terrorism Act 2000, highlights weaknesses in the government's plans to roll existing agencies, including the internationally respected Public Health Laboratory Service, into a new Health Protection Agency.

An HPA document leaked to The Scientist by the Conservative Party warns that the strategy of amalgamating the various agencies currently charged with protecting public health carries with it intrinsic risks. At least in the short term, the new setup would be poorly equipped to cope with a major emergency, such as a deliberately released bio-agent.

The paper states, "It seems inevitable if the timetable of 1st April 2003 for the HPA is to be delivered, some level of risk will have to be tolerated. Were there to be a severe external challenge over the next few months, such as deliberate release, the situation and expected ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Pete Moore

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide